Inhibition of IgE Production by the Imidazoquinoline Resiquimod in Nonallergic and Allergic Donors
- 1 November 2002
- journal article
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 119 (5), 1059-1064
- https://doi.org/10.1046/j.1523-1747.2002.19531.x
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Small anti-viral compounds activate immune cells via the TLR7 MyD88–dependent signaling pathwayNature Immunology, 2002
- Daily or Weekly Therapy with Resiquimod (R‐848) Reduces Genital Recurrences in Herpes Simplex Virus–Infected Guinea Pigs during and after TreatmentThe Journal of Infectious Diseases, 2001
- Adjuvant Activities of Immune Response Modifier R-848: Comparison with CpG ODNCellular Immunology, 2000
- Oligonucleotide therapy of allergic asthmaJournal of Allergy and Clinical Immunology, 1999
- Modulation of TH1 and TH2 Cytokine Production with the Immune Response Modifiers, R-848 and ImiquimodCellular Immunology, 1999
- Insect venom immunotherapy induces interleukin‐10 production and a Th2‐to‐Th1 shift, and changes surface marker expression in venom‐allergic subjectsEuropean Journal of Immunology, 1997
- Structure and Functions of CD23International Reviews of Immunology, 1997
- IFN-γ represses ε germline transcription and subsequently down-regulates switch recombination to εInternational Immunology, 1994
- Systemic interferon gamma treatment in severe atopic dermatitisJournal of the American Academy of Dermatology, 1993
- Recombinant interferon gamma therapy for atopic dermatitisJournal of the American Academy of Dermatology, 1993